ARCA biopharma Inc [ABIO] stock Initiated by Ascendiant Capital Markets analyst, price target now $2
ARCA biopharma Inc [NASDAQ: ABIO] stock went on an upward path that rose over 90.06% on Wednesday, amounting to a one-week price increase of more than 90.06%. The company report on April 3, 2024 at 7:30 AM that ARCA biopharma and Oruka Therapeutics Announce Merger